Library Home | Reset filters
Select one or more filter options and click search below.
Lakeshia Cousin; Stephanie Roberts; Naomi C. Brownstein (et al.)
Raffaella Baccolini; Chiara Xausa
Hannah Sell; Yuba Raj Paudel; Donald Voaklander (et al.)
Few studies have assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on immunization coverage for adolescents, and little is known about how coverage has changed throughout the pandemic. This study aimed to: (1) assess the change in coverage for school-based vaccines in Alberta, Canada resulting from the pandemic; (2) determine whether coverage differed by geographic health zone and school type; and (3) ascertain whether coverage has returned to pre-pandemic levels. Using a retrospective cohort design, this study used administrative health data to compare coverage for human papillomavirus (HPV) and meningococcal conjugate A, C, Y, W-135 (MenC-ACYW) vaccines between pre-pandemic (2017–2018 school year) and pandemic (2019–2020 and 2020–2021 school years) cohorts (N = 289,420). Coverage was also compared by health zone and authority type. The 2019–2020 cohort was followed over one year to assess catch-up.
Carina C. Santos; Fernanda W. de M. Lima; Laio Magno (et al.)
Brazil was strongly affected by the COVID-19 pandemic and the impact of the pandemic on sexual and gender minorities’ youth remains unknown. This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies and associated factors among adolescent men who have sex with men (AMSM) and transgender women (ATGW) participants of a human immunodeficiency virus (HIV) pre-exposure prophylaxis cohort study (PrEP1519). This is a cross-sectional design conducted between June and October 2020 in Salvador, Brazil. Serum samples were collected from AMSM and ATGW aged 16-21 years between June-October 2020. IgG and IgM anti-SARS-CoV-2 were detected by chemiluminescence immunoassay, and data were collected through a socio-behavioral questionnaire.
Sawsan Abuhammad; Hossam Alhawatmeh; Ahlam Al-Natour (et al.)
This study aimed to describe the level of knowledge of undergraduate students in Jordan toward COVID-19 in children in respect of the clinical signs of the disease, modes of transmission, protection measures against the disease and satisfaction with governmental measures. A cross-section was utilized in this study. An online survey questionnaire was utilized in this research study. All undergraduate students in Jordan were able to take part. The size of the sample was 799. Knowledge toward COVID-19 among children was used to assess the participants' knowledge about COVID-19.
Kechun Zhang; Xue Liang; Karen Lau Wa Tam (et al.)
Moshe Hoshen; Vered Shkalim Zemer; Shai Ashkenazi (et al.)
This study has three aims: to elucidate determinants associated with COVID-19 vaccine uptake in children and the association with parental vaccination; to compare rates of PCR-positive SARS-CoV-2 results between vaccinated and unvaccinated children; to estimate the rate of parental COVID-19 vaccination and its association with the vaccination rate of their children. It performed a retrospective chart review of all children aged 5–11 years registered at a central district in Israel from November 21st, 2021 to April 30th, 2022, and characterized COVID-19 vaccinated vs. unvaccinated individuals. Data retrieved from the electronic medical files included: demographics [age, gender, sector, socioeconomic status (SES)]; COVID-19 vaccination (first and second doses) and influenza vaccination status; co-morbidities; and parental vaccinations for COVID-19. It divided the population into three distinct demographic groups: non-ultra-orthodox Jews (43,889 children), ultra-orthodox Jews (13,858 children), and Arabs (4,029 children).
Anna-Clara Rönner; Anna Jakobsson; Niklas Gericke
Zaufishan Zaufishan; Muhammad Usman; Khandah Fishan Mumtaz (et al.)
The elevated risk of serious complications like myocarditis and pericarditis after COVID-19 vaccination, especially in adolescent has been reported in some instances that need to be tested in regional populations and different ethnicity groups. The purpose of the study was to evaluate the side effects, hesitancy, and effectiveness outcomes following COVID-19 vaccination among children in Pakistan. The study was planned using a cross-sectional design and data from Children and Adolescents (CA) was collected through a convenient sampling method using a validated questionnaire between February to July 2022. A total of 1,108 CA between the age of 12–18 years who received one or two doses of vaccine were selected and data were collected through direct interviews with respondents.
Melissa S. Stockwell; Christina A. Porucznik; Ashton Dixon (et al.)
Millions of children have tested positive for SARS-CoV-2, and over 1000 children have died in the US. However, vaccination rates for children 5 to 11 years old are low. Starting in August 2020, we conducted a prospective SARS-CoV-2 household surveillance study in Spanish and English-speaking households in New York City and Utah. From October 21 to 25, 2021, we asked caregivers about their likelihood of getting COVID-19 vaccine for their child, and reasons that they might or might not vaccinate that child. We compared intent to vaccinate by site, demographic characteristics, SARS-CoV-2 infection detected by study surveillance, and parents’ COVID-19 vaccination status using Chi-square tests and a multivariable logistic regression model, accounting for within-household clustering.
Eduardo Jorge da Fonseca Lima; Robério Dias Leite
Covid-19 had a direct impact on children's health. The aim of this review was to analyze epidemiological and clinical data, the consequences of the pandemic, and vaccination aspects in this group. The searches were carried out from January 2020 to November 2022, in the MEDLINE databases (PubMed) and publications of the Brazilian Ministry of Health and the Brazilian Society of Pediatrics.
Marcio Fernandes Nehab; Karla Gonçalves Camacho; Adriana Teixeira Reis (et al.)
The vaccination of children and adolescents for the prevention of Covid-19 is important to:decrease in deaths and hospitalizations, prevent multisystem inflammatory syndrome, avoid long-term complications and decrease the suspension of on-site classes. Despite of these benefits, some studies have shown that some caregivers are still hesitancy. This is a voluntary and anonymous online survey conducted from November 17 to December 14, 2021, in Brazil, through a free-of-charge platform with a link provided on social networks. A bivariate analysis was conducted with the independent variables, with vaccine hesitancy as the outcome variable, and a multivariate logistic model was used to calculated adjusted odds ratios.
Karima Chaabna; Sonia Chaabane; Anupama Jithesh (et al.)
Safety measures implemented to address the COVID-19 pandemic have had a profound impact on the mobility of people worldwide. This study synthesized the global evidence on physical activity (PA) participation before and during the pandemic. It conducted a systematic review, searching PubMed, Embase, WHO Global literature on coronavirus disease (between January 2020 and April 2022), and reference lists. Meta-analysis and meta-regression were conducted to quantitatively synthesize the data.
Cassandra Pingali; Fan Zhang; Tammy A. Santibanez (et al.)
Although COVID-19–associated illness is generally mild in adolescents, they can experience severe health outcomes, including hospitalization and death.1 COVID-19 vaccinations are effective for preventing serious COVID-19–associated illness in adolescents.1 The Advisory Committee on Immunization Practices (ACIP) recommends persons aged 6 months or older receive COVID-19 vaccination.2 As of April 14, 2022, among US individuals aged 12 to 17 years, COVID-19 vaccination coverage (≥1 dose) was 68%,3 lower than for other vaccines routinely recommended for adolescents.4 The ACIP recommends adolescents aged 11 to 12 years receive tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MenACWY), and human papillomavirus (HPV) vaccinations.2 This cross-sectional study investigated associations between routine adolescent vaccination status and parental intent or hesitancy to get a COVID-19 vaccine for their adolescent. The National Immunization Survey–Child COVID Module (NIS-CCM) is a national telephone survey of households with children or adolescents aged 6 months to 17 years used to measure parent-reported COVID-19 vaccination coverage and intent to vaccinate their child.5 The NIS-CCM uses the NIS-Child sampling frame; for adolescents aged 13 to 17 years, it follows the NIS-Teen interview, allowing for analysis of both routine (HPV, MenACWY, and Tdap) and COVID-19 vaccination coverage.5 NIS-CCM interviews from July 22, 2021, through February 26, 2022, were analyzed. Survey respondents were those self-reporting being most knowledgeable about the child’s vaccinations (hereafter, parent). Vaccination status was based on parental report. Data were weighted to represent the noninstitutionalized population of US adolescents and calibrated to administered vaccinations data.3 Analyses were performed using SAS, version 9.4
Steward Mudenda; Moses Mukosha; Brian Godman (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response